Rapidly Progressive Glomerulonephritis.
Rout P, Naik RH, Leslie SW.
2024 Jun 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
Rapidly progressive crescentic glomerulonephritis: Early treatment is a must.
Moroni G, Ponticelli C.
Autoimmun Rev. 2014 Jul;13(7):723-9. doi: 10.1016/j.autrev.2014.02.007. Epub 2014 Mar 19.
Nephrotic syndrome: pathophysiology and consequences.
Claudio P, Gabriella M.
J Nephrol. 2023 Nov;36(8):2179-2190. doi: 10.1007/s40620-023-01697-7. Epub 2023 Jul 19.
Histopathologic classification of ANCA-associated glomerulonephritis.
Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, Neumann I, Noël LH, Pusey CD, Waldherr R, Bruijn JA, Bajema IM.
J Am Soc Nephrol. 2010 Oct;21(10):1628-36. doi: 10.1681/ASN.2010050477. Epub 2010 Jul 8.
Rapidly progressive crescentic glomerulonephritis.
Jennette JC.
Kidney Int. 2003 Mar;63(3):1164-77. doi: 10.1046/j.1523-1755.2003.00843.x.
Treatment of IgA Nephropathy: A Rapidly Evolving Field.
El Karoui K, Fervenza FC, De Vriese AS.
J Am Soc Nephrol. 2024 Jan 1;35(1):103-116. doi: 10.1681/ASN.0000000000000242. Epub 2023 Sep 29.
STING1 deficiency ameliorates immune-mediated crescentic glomerulonephritis in mice.
García-Giménez J, Córdoba-David G, Rayego-Mateos S, Cannata-Ortiz P, Carrasco S, Ruiz-Ortega M, Fernandez-Fernandez B, Ortiz A, Ramos AM.
J Pathol. 2023 Nov;261(3):309-322. doi: 10.1002/path.6177. Epub 2023 Aug 31.
Rapidly progressive crescentic diabetic nephropathy: two case reports.
Schroers JE, Gilbert AM, McKenzie PR, Kirwan PD, Chadban SJ, Ying T.
Intern Med J. 2022 Mar;52(3):479-484. doi: 10.1111/imj.15702.
Pauci-immune crescentic glomerulonephritis.
Gupta RK.
Indian J Pathol Microbiol. 2003 Jul;46(3):357-66.
Severe psoriasis presenting with rapidly progressive (crescentic) IgA-predominant glomerulonephritis.
Garces CC, Hernandez Garcilazo N, Sharma A, Nader G.
BMJ Case Rep. 2021 May 26;14(5):e242627. doi: 10.1136/bcr-2021-242627.
